We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Can Be First to Market With Generic of Eisai’s Aricept
Ranbaxy Can Be First to Market With Generic of Eisai’s Aricept
September 28, 2010
Ranbaxy Laboratories has been informed by the FDA that, pending approval of its ANDA, it would be the first company permitted to market a generic version of Eisai’s blockbuster Alzheimer’s drug Aricept.